The DOI matches its Crossref record; 41 of the 41 references it cites were found in a registry or an index.
c-Abl Has High Intrinsic Tyrosine Kinase Activity That Is Stimulated by Mutation of the Src Homology 3 Domain and by Autophosphorylation at Two Distinct Regulatory Tyrosines
Open accessAbstract
Using the specific Abl tyrosine kinase inhibitor STI 571, we purified unphosphorylated murine type IV c-Abl and measured the kinetic parameters of c-Abl tyrosine kinase activity in a solution with a peptide-based assay. Unphosphorylated c-Abl exhibited substantial peptide kinase activity with K(m) of 204 microm and V(max) of 33 pmol min(-1). Contrary to previous observations using immune complex kinase assays, we found that a transforming c-Abl mutant with a Src homology 3 domain point mutation (P131L) had significantly (about 6-fold) higher intrinsic kinase activity than wild-type c-Abl (K(m) = 91 microm, V(max) = 112 pmol min(-1)). Autophosphorylation stimulated the activity of wild-type c-Abl about 18-fold and c-Abl P131L about 3.6-fold, resulting in highly active kinases with similar catalytic rates. The autophosphorylation rate was dependent on Abl protein concentration consistent with an intermolecular reaction. A tyrosine to phenylalanine mutation (Y412F) at the c-Abl residue homologous to the c-Src catalytic domain autophosphorylation site impaired the activation of wild-type c-Abl by 90% but reduced activation of c-Abl P131L by only 45%. Mutation of a tyrosine (Tyr-245) in the linker region between the Src homology 2 and catalytic domains that is conserved among the Abl family inhibited the autophosphorylation-induced activation of wild-type c-Abl by 50%, whereas the c-Abl Y245F/Y412F double mutant was minimally activated by autophosphorylation. These results support a model where c-Abl is inhibited in part through an intramolecular Src homology 3-linker interaction and stimulated to full catalytic activity by sequential phosphorylation at Tyr-412 and Tyr-245.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Effects of a selective inhibitor of the Abl tyrosine kinase on the growth of Bcr-Abl positive cells
Druker, B. J., Tamura, S., Buchdunger, E., Ohno, S., Segal, G. M., Fanning, S., Zimmermann, J., & Lydon, N. B. (1996) · Nature Medicine · doi:10.1038/nm0596-561 · Cited by 2,967
Structural Mechanism for STI-571 Inhibition of Abelson Tyrosine Kinase
Schindler, T., Bornmann, W., Pellicena, P., Miller, W. T., Clarkson, B., & Kuriyan, J. (2000) · Science · doi:10.1126/science.289.5486.1938 · Cited by 1,780
Three-dimensional structure of the tyrosine kinase c-Src
Xu, W., Harrison, S. C., & Eck, M. J. (1997) · Nature · doi:10.1038/385595a0 · Cited by 1,418
Crystal structure of the Src family tyrosine kinase Hck
Sicheri, F., Moarefi, I., & Kuriyan, J. (1997) · Nature · doi:10.1038/385602a0 · Cited by 1,172
Analysis of mutation in human cells by using an Epstein-Barr virus shuttle system.
DuBridge, R. B., Tang, P., Hsia, H. C., Leong, P. M., Miller, J. H., & Calos, M. P. (1987) · Molecular and Cellular Biology · doi:10.1128/mcb.7.1.379 · Cited by 1,133
Crystal structure of the tyrosine kinase domain of the human insulin receptor
Hubbard, S. R., Wei, L., & Hendrickson, W. A. (1994) · Nature · doi:10.1038/372746a0 · Cited by 1,080
Buchdunger, E., Zimmermann, J., Mett, H., Meyer, T., Müller, M., Druker, B. J., & Lydon, N. (1996) · PubMed · Cited by 1,057
Catalytic specificity of protein-tyrosine kinases is critical for selective signalling
Songyang, Z., Carraway, K. L., Eck, M. J., Harrison, S. C., Feldman, R. A., Mohammadi, M., Schlessinger, J., Hubbard, S. R., Smith, D. P., Eng, C., et al. (1995) · Nature · doi:10.1038/373536a0 · Cited by 919
Kmiecik, T. E., & Shalloway, D. (1987) · Cell · doi:10.1016/0092-8674(87)90756-2 · Cited by 623
Activation of the Sire-family tyrosine kinase Hck by SH3 domain displacement
Moarefi, I., LaFevre-Bernt, M., Sicheri, F., Huse, M., Lee, C.-H., Kuriyan, J., & Miller, W. T. (1997) · Nature · doi:10.1038/385650a0 · Cited by 601
Baskaran, R., Wood, L. D., Whitaker, L. L., Canman, C. E., Morgan, S. E., Xu, Y., Barlow, C., Baltimore, D., Wynshaw-Boris, A., Kastan, M. B., et al. (1997) · Nature · doi:10.1038/387516a0 · Cited by 539
Tyrosine phosphorylation regulates the biochemical and biological properties of pp60c-src
Piwnica-Worms, H., Saunders, K. B., Roberts, T. M., Smith, A. E., & Cheng, S. H. (1987) · Cell · doi:10.1016/0092-8674(87)90757-4 · Cited by 520
Activation of the c-Abl tyrosine kinase in the stress response to DMA-damaging agents
Kharbanda, S., Ren, R., Pandey, P., Shafman, T. D., Feller, S. M., Weichselbaum, R. R., & Kufe, D. W. (1995) · Nature · doi:10.1038/376785a0 · Cited by 485
Plattner, R., Kadlec, L., DeMali, K. A., Kazlauskas, A., & Pendergast, A. M. (1999) · Genes & Development · doi:10.1101/gad.13.18.2400 · Cited by 427
Van Etten, R. A., Jackson, P., & Baltimore, D. (1989) · Cell · doi:10.1016/0092-8674(89)90102-5 · Cited by 413
Self-citationWelch, P. (1993) · Cell · doi:10.1016/0092-8674(93)90497-e · Cited by 407
c-Abl kinase regulates the protein binding activity of c-Crk.
Feller, S. M., Knudsen, B., & Hanafusa, H. (1994) · The EMBO Journal · doi:10.1002/j.1460-2075.1994.tb06518.x · Cited by 363
Cycling, stressed-out and nervous: cellular functions of c-Abl
Van Etten, R. A. (1999) · Trends in Cell Biology · doi:10.1016/s0962-8924(99)01549-4 · Cited by 321
Self-citationIntegrin regulation of c-Abl tyrosine kinase activity and cytoplasmic–nuclear transport
Lewis, J. M., Baskaran, R., Taagepera, S., Schwartz, M. A., & Wang, J. Y. J. (1996) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.93.26.15174 · Cited by 311
Mayer, B. J., Jackson, P. K., Van Etten, R. A., & Baltimore, D. (1992) · Molecular and Cellular Biology · doi:10.1128/mcb.12.2.609 · Cited by 288
Self-citationN-terminal mutations activate the leukemogenic potential of the myristoylated form of c-abl.
Jackson, P., & Baltimore, D. (1989) · The EMBO Journal · doi:10.1002/j.1460-2075.1989.tb03397.x · Cited by 278
Dai, Z., & Pendergast, A. M. (1995) · Genes & Development · doi:10.1101/gad.9.21.2569 · Cited by 269
Wen, S.-T., & Van Etten, R. A. (1997) · Genes & Development · doi:10.1101/gad.11.19.2456 · Cited by 265
Self-citationShi, Y., Alin, K., & Goff, S. P. (1995) · Genes & Development · doi:10.1101/gad.9.21.2583 · Cited by 247
An intramolecular SH3-domain interaction regulates c-Abl activity
Barilá, D., & Superti-Furga, G. (1998) · Nature Genetics · doi:10.1038/ng0398-280 · Cited by 216
Franz, W. M., Berger, P., & Wang, J. Y. (1989) · The EMBO Journal · doi:10.1002/j.1460-2075.1989.tb03358.x · Cited by 202
Wen, S. T., Jackson, P. K., & Van Etten, R. A. (1996) · The EMBO Journal · doi:10.1002/j.1460-2075.1996.tb00503.x · Cited by 200
Self-citationBarker, S., Kassel, D. B., Weigl, D., Huang, X., Luther, M., & Knight, W. B. (1995) · Biochemistry · doi:10.1021/bi00045a027 · Cited by 190
Mutagenic analysis of the roles of SH2 and SH3 domains in regulation of the Abl tyrosine kinase.
Mayer, B. J., & Baltimore, D. (1994) · Molecular and Cellular Biology · doi:10.1128/mcb.14.5.2883 · Cited by 178
Seidel-Dugan, C., Meyer, B. E., Thomas, S. M., & Brugge, J. S. (1992) · Molecular and Cellular Biology · doi:10.1128/mcb.12.4.1835 · Cited by 175
Potential positive and negative autoregulation of p60c-src by intermolecular autophosphorylation.
Cooper, J. A., & MacAuley, A. (1988) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.85.12.4232 · Cited by 170
Hirai, H., & VARMUS, H. E. (1990) · Molecular and Cellular Biology · doi:10.1128/mcb.10.4.1307 · Cited by 151
Evidence for regulation of the human ABL tyrosine kinase by a cellular inhibitor.
Pendergast, A. M., Muller, A. J., Havlik, M. H., Clark, R., McCormick, F. P., & Witte, O. N. (1991) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.88.13.5927 · Cited by 139
Boerner, R. J., Kassel, D. B., Barker, S. C., Ellis, B., DeLacy, P., & Knight, W. B. (1996) · Biochemistry · doi:10.1021/bi960248u · Cited by 92
A nuclear tyrosine phosphorylation circuit: c‐Jun as an activator and substrate of c‐Abl and JNK
Barilà, D., Mangano, R., Gonfloni, S., Kretzschmar, J., Moro, M., Bohmann, D., & Superti‐Furga, G. (2000) · The EMBO Journal · doi:10.1093/emboj/19.2.273 · Cited by 87
Leucine 255 of Src couples intramolecular interactions to inhibition of catalysis.
Superti‐Furga, G., Gonfloni, S., Frischknecht, F., & Way, M. (1999) · Nature Structural Biology · doi:10.1038/11537 · Cited by 64
Smith, J. M., Katz, S., & Mayer, B. J. (1999) · Journal of Biological Chemistry · doi:10.1074/jbc.274.39.27956 · Cited by 46
c-ABL Tyrosine Kinase Activity Is Regulated by Association with a Novel SH3-Domain-Binding Protein
Zhu, J., & Shore, S. K. (1996) · Molecular and Cellular Biology · doi:10.1128/mcb.16.12.7054 · Cited by 41
An Activating Mutation in the ATP Binding Site of the ABL Kinase Domain
Allen, P. B., & Wiedemann, L. M. (1996) · Journal of Biological Chemistry · doi:10.1074/jbc.271.32.19585 · Cited by 33
Agami, R., & Shaul, Y. (1998) · Oncogene · doi:10.1038/sj.onc.1201708 · Cited by 27
Reynolds, F. H., Oroszlan, S., & Stephenson, J. R. (1982) · Journal of Virology · doi:10.1128/jvi.44.3.1097-1101.1982 · Cited by 18
Cited by
O'Hare, T., Walters, D. K., Stoffregen, E. P., Jia, T., Manley, P. W., Mestan, J., Cowan-Jacob, S. W., Lee, F. Y., Heinrich, M. C., Deininger, M. W. N., et al. (2005) · Cancer Research · doi:10.1158/0008-5472.can-05-0259 · Cited by 1,036
Structural Basis for the Autoinhibition of c-Abl Tyrosine Kinase
Nagar, B., Hantschel, O., Young, M. A., Scheffzek, K., Veach, D., Bornmann, W., Clarkson, B., Superti-Furga, G., & Kuriyan, J. (2003) · Cell · doi:10.1016/s0092-8674(03)00194-6 · Cited by 879
Branford, S., Rudzki, Z., Walsh, S., Grigg, A., Arthur, C., Taylor, K., Herrmann, R., Lynch, K. P., & Hughes, T. P. (2002) · Blood · doi:10.1182/blood.v99.9.3472 · Cited by 649
Tau protein kinases: Involvement in Alzheimer's disease
Martin, L., Latypova, X., Wilson, C. M., Magnaudeix, A., Perrin, M.-L., Yardin, C., & Terro, F. (2013) · Ageing Research Reviews · doi:10.1016/j.arr.2012.06.003 · Cited by 631
Coyne, C. B., & Bergelson, J. M. (2006) · Cell · doi:10.1016/j.cell.2005.10.035 · Cited by 547
Metadata
- Authors
- Brasher, B. B., & Van Etten, R. A.
- Venue
- Journal of Biological Chemistry
- Publisher
- Elsevier BV
- Published
- 2000-11
- Volume
- 275
- Issue
- 45
- Pages
- 35631-35637
- ISSN
- 0021-9258 (ISSN-L)
- OpenAlex
- W1997577435
- Cited by
- 278
- References
- 41
- FWCI
- 4.73
- Type
- journal article
- Language
- en
- Open access
- hybrid
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.